QQQ $ 454.82 $ -0.58 (-0.13 %)
DIA $ 398.57 $ -2.09 (-0.52 %)
SPY $ 530.36 $ -1.09 (-0.21 %)
TLT $ 91.26 $ 0.43 (0.47 %)
GLD $ 225.37 $ -4.09 (-1.82 %)
$ 0.24
-- x --
-- x --
-- - --
$ 0.20 - $ 0.55
625,003
na
90.05M
$ 1.01
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-07-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-04-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-03-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-16-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 05-17-2021 03-31-2021 10-Q
14 03-23-2021 12-31-2020 10-K
15 11-09-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-28-2020 03-31-2020 10-Q
18 04-01-2020 12-31-2019 10-K
19 11-29-2019 09-30-2019 10-Q
20 08-09-2019 06-30-2019 10-Q
21 05-10-2019 03-31-2019 10-Q
22 04-16-2019 12-31-2018 10-K
23 11-14-2018 09-30-2018 10-Q
24 08-14-2018 06-30-2018 10-Q
25 05-15-2018 03-31-2018 10-Q
26 04-02-2018 12-31-2017 10-K
27 11-14-2017 09-30-2017 10-Q
28 08-14-2017 06-30-2017 10-Q
29 05-15-2017 03-31-2017 10-Q
30 04-17-2017 12-31-2016 10-K
31 12-22-2016 09-30-2016 10-Q
32 12-19-2016 06-30-2016 10-Q
33 11-01-2016 03-31-2016 10-Q
34 09-27-2016 12-31-2015 10-K
35 11-16-2015 09-30-2015 10-Q
36 08-19-2015 06-30-2015 10-Q
37 06-22-2015 03-31-2015 10-Q
38 06-09-2015 12-31-2014 10-K
39 11-14-2014 09-30-2014 10-Q
40 08-14-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cannabis-rescheduling-signals-strong-returns-tax-breaks-could-increase-this-stocks-market-cap-by-170

According to a recent report by Pablo Zuanic of Zuanic & Associates, MariMed (OTC: MRMD) a multi-state cannabis operator (M...

 analysts-may-need-to-revise-cannabis-stock-projections-for-2024-10-companies-surpass-ebitda-estimates-by-37m

Cannabis equity analysts may need to revise their 2024 earnings estimates after first-quarter results from major multi-state op...

 cannabis-chart-of-the-week-analysts-react-meekly-to-strong-q124-earnings

In our January 2024 outlook, we asserted that cannabis equity analysts, having been burned by the need for continual downward r...

 marimed-q1-sales-37933m-beat-36950m-estimate

MariMed (OTC:MRMD) reported quarterly sales of $37.933 million which beat the analyst consensus estimate of $36.950 million by ...

 cannabis-industry-leaders-react-to-deas-historic-move-to-reschedule-cannabis

the U.S. Drug Enforcement Administration (DEA) is reportedly moving cannabis from Schedule I to Schedule III

 marimed-is-on-a-roll-partners-with-two-iconic-music-venues-in-boston-acquires-another-illinois-cannabis-dispensary

Multi-state marijuana operator MariMed has closed the acquisition of Allgreens Dispensary, LLC on Tuesday, April 9, its fifth d...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION